Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Receivables | 9 | N/A | N/A |
| Inventories | 423 | N/A | N/A |
| TOTAL | $484 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 4 | N/A | N/A |
| Other Non-Current Assets | 75 | 0 | 0 |
| TOTAL | $79 | $N/A | $N/A |
| Total Assets | $562 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 103 | 0 | 0 |
| Accrued Expenses | 276 | N/A | N/A |
| Other current liabilities | 84 | N/A | N/A |
| TOTAL | $463 | $N/A | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $463 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 3 | N/A | N/A |
| Retained earnings | -632 | N/A | N/A |
| TOTAL | $99 | $N/A | $N/A |
| Total Liabilities And Equity | $562 | $0 | $0 |